Zhaoqian Liu

机构：Central South University, National Clinical Research Center for Digestive Diseases, National Clinical Research, PharmacoGenetics (China), Xiangya Hospital Central South University, University of South China · ORCID：0000-0001-5724-1516

发表论文 40 篇 · 总被引 589 次 · h-index 11

代表论文

• Simultaneous Activation of Pyroptosis and cGAS‐STING Pathway with Epigenetic/ Photodynamic Nanotheranostic for Enhanced Tumor Photoimmunotherapy (2023 · Advanced Materials · 被引 102)
• Application of physiologically based pharmacokinetic modeling of novel drugs approved by the U.S. food and drug administration (2024 · European Journal of Pharmaceutical Sciences · 被引 59)
• Novel insights into HBV‐hepatocellular carcinoma at single‐cell sequencing (2023 · MedComm – Oncology · 被引 20)
• eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin (2023 · Biochemical Pharmacology · 被引 19)
• Unveiling the shield: Troglitazone's impact on epilepsy‐induced nerve injury through ferroptosis inhibition (2024 · CNS Neuroscience & Therapeutics · 被引 11)
• Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors (2024 · Journal for ImmunoTherapy of Cancer · 被引 11)